JUL 15, 2026 · JOURNAL ARTICLE
Disease-Modifying Therapies for Hereditary Transthyretin Amyloidosis with Polyneuropathy: Current Status and Future Perspectives
Neurology and Therapy
This is a narrative review summarizing current disease-modifying therapies for ATTRv-PN, comparing mechanisms and clinical evidence to guide clinical practice, rather than reporting original research findings.